Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig N Robson

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Communications Biology|March 6, 2024
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancerRebecca Garnham, Daniel Geh, Ryan Nelson, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2014
Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus PanelJohn M Fitzpatrick, Joaquim Bellmunt, Karim Fizazi, et al.
Cancer Research|April 6, 2026
SET1B Drives Sustained HIF activity and Disease Progression in Clear Cell Renal Cell CarcinomaBrian M Ortmann, Tekle Pauzaite, James A C Bertlin, et al.
Molecular Cancer Therapeutics|July 18, 2013
AZD3514: a small molecule that modulates androgen receptor signaling and function in vitro and in vivoSarah A Loddick, Sarah J Ross, Andrew G Thomason, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Communications Biology|March 6, 2024
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancerRebecca Garnham, Daniel Geh, Ryan Nelson, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2014
Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus PanelJohn M Fitzpatrick, Joaquim Bellmunt, Karim Fizazi, et al.
Cancer Research|April 6, 2026
SET1B Drives Sustained HIF activity and Disease Progression in Clear Cell Renal Cell CarcinomaBrian M Ortmann, Tekle Pauzaite, James A C Bertlin, et al.
Molecular Cancer Therapeutics|July 18, 2013
AZD3514: a small molecule that modulates androgen receptor signaling and function in vitro and in vivoSarah A Loddick, Sarah J Ross, Andrew G Thomason, et al.
Pageof 10